IOX1 activity as sepsis therapy and an antibiotic against multidrug-resistant bacteria
Abstract Sepsis is caused by organ dysfunction initiated by an unrestrained host immune response to infection. The emergence of antibiotic-resistant bacteria has rapidly increased in the last decades and has stimulated a firm research platform to combat infections caused by antibiotic-resistant bact...
Main Authors: | Su Jin Lee, Jueng Soo You, Amal Gharbi, Yong Joo Kim, Mi Suk Lee, Dong Hwan Kim, Keun Woo Lee, In Duk Jung, Yeong Min Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-82377-z |
Similar Items
-
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
by: Jing Liu, et al.
Published: (2021-04-01) -
A Novel Peptide Derived from the Transmembrane Domain of Romo1 Is a Promising Candidate for Sepsis Treatment and Multidrug-Resistant Bacteria
by: Deok-Gyun You, et al.
Published: (2021-07-01) -
Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis
by: Hye-Ra Lee, et al.
Published: (2020-04-01) -
IOX-101, a novel small molecule, reduces AML cell proliferation by Akt enzyme inhibition
by: Prasanna Rajagopalan, et al.
Published: (2018-01-01) -
Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
by: Daniele Roberto Giacobbe, et al.
Published: (2020-04-01)